This study reveals the extensive genomic responses that result from MEK inhibition in 501mel melanoma cells, including widespread remodeling of the active chromatin landscape, increased recruitment of SOX10 binding to the genome, and re-activation of melanocyte pigmentation and developmental transcriptional programs. The gene discussed is MAP2K7; the disease is melanoma.